Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Neurological Clinic - Texas
mi
from
Dallas, TX
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Neurological Clinic - Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Baylor College of Medicine
mi
from
Houston, TX
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Todd Swick, MD, PA
mi
from
Houston, TX
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Todd Swick, MD, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
UT Health Science Center - Houston
mi
from
Houston, TX
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
UT Health Science Center - Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Neurological Associates of Washington/Clinical Trials of America Inc.
mi
from
Bellevue, WA
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Neurological Associates of Washington/Clinical Trials of America Inc.
mi
from
Bellevue, WA
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Pacific Medical Centers
mi
from
Seattle, WA
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Pacific Medical Centers
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
West Virginia University
mi
from
Morgantown, WV
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
West Virginia University
mi
from
Morgantown, WV
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Clinical Research Consortium
mi
from
Phoenix, AZ
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Clinical Research Consortium
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
American Institute of Research
mi
from
Los Gatos, CA
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
American Institute of Research
mi
from
Los Gatos, CA
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Tallahassee Neurological Clinic
mi
from
Tallahassee, FL
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Tallahassee Neurological Clinic
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
John Hopkins University
mi
from
Baltimore, MD
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
John Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Cooper University Health System
mi
from
Cherry Hill, NJ
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Cooper University Health System
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
University Medicine and Dentistry of New Jersey
mi
from
New Brunswick, NJ
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
University Medicine and Dentistry of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Wake Forest University
mi
from
Winstom-Salem, NC
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Wake Forest University
mi
from
Winstom-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Texas Neurology, PA
mi
from
Dallas, TX
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Texas Neurology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Neurology Associates of Arlington, PA
mi
from
Mansfield, TX
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Neurology Associates of Arlington, PA
mi
from
Mansfield, TX
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Sentara Neurology Specialists
mi
from
Norfolk, VA
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Sentara Neurology Specialists
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
Click here to add this to my saved trials
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated:  2/9/2016
London Health Sciences Center
mi
from
London,
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Status: Enrolling
Updated: 2/9/2016
London Health Sciences Center
mi
from
London,
Click here to add this to my saved trials
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
mi
from
Orange, CA
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
mi
from
Spring Hill, FL
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
mi
from
Spring Hill, FL
Click here to add this to my saved trials
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
mi
from
Destrehan, LA
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
mi
from
Destrehan, LA
Click here to add this to my saved trials
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
Preventing Post-Operative Delirium in Pneumonectomy, Esophagectomy and Thoracotomy Patients
Status: Enrolling
Updated:  2/9/2016
University Hospital
mi
from
Indianapolis, IN
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
Preventing Post-Operative Delirium in Pneumonectomy, Esophagectomy and Thoracotomy Patients
Status: Enrolling
Updated: 2/9/2016
University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Neurocognitive Effects of Bilateral STN Versus GPi DBS in Parkinson's Disease Patients With MCI
Neurocognitive Effects of Bilateral Subthalamic Nucleus Versus Globus Pallidus Interna Deep Brain Stimulation in Parkinson's Disease Patients With Mild Cognitive Impairment
Status: Enrolling
Updated:  2/9/2016
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Neurocognitive Effects of Bilateral STN Versus GPi DBS in Parkinson's Disease Patients With MCI
Neurocognitive Effects of Bilateral Subthalamic Nucleus Versus Globus Pallidus Interna Deep Brain Stimulation in Parkinson's Disease Patients With Mild Cognitive Impairment
Status: Enrolling
Updated: 2/9/2016
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Albany Medical College
mi
from
Albany, NY
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Baylor College of Medicine
mi
from
Houston, TX
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Booth Gardner Parkinson's Care Center (Evergreen Healthcare)
mi
from
Kirkland, WA
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Booth Gardner Parkinson's Care Center (Evergreen Healthcare)
mi
from
Kirkland, WA
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Cleveland Clinic
mi
from
Cleveland, OH
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Columbia University Medical Center
mi
from
New York, NY
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Cooper University Hospital
mi
from
Camden, NJ
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Duke University
mi
from
Durham, NC
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Emory University School of Medicine
mi
from
Atlanta, GA
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Augusta University
mi
from
Augusta, GA
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Hereditary Neurological Disease Center (HNDC)
mi
from
Wichita, KA
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Hereditary Neurological Disease Center (HNDC)
mi
from
Wichita, KA
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Indiana University
mi
from
Indianapolis, IN
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Massachusetts General Hospital
mi
from
Boston, MA
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Medical University of South Carolina
mi
from
Charleston, SC
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Nebraska Medical Center
mi
from
Omaha, NE
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Nebraska Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
North Shore-LIJ Health System
mi
from
Manhasset, NY
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
North Shore-LIJ Health System
mi
from
Manhasset, NY
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Ohio State University
mi
from
Columbus, OH
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Rush University Medical Center
mi
from
Chicago, IL
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
Struthers Parkinson's Center
mi
from
Golden Valley, MN
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
Struthers Parkinson's Center
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
University of California-Davis
mi
from
Sacramento, CA
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
University of California, Irvine
mi
from
Irvine, CA
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
University of Cincinnati
mi
from
Cincinnati, OH
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated:  2/10/2016
University of Connecticut
mi
from
Farmington, CT
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Status: Enrolling
Updated: 2/10/2016
University of Connecticut
mi
from
Farmington, CT
Click here to add this to my saved trials